(Q37278137)

19 August 2017

1 reference

title

Active surveillance for prostate cancer: trials and tribulations (English)

1 reference

19 August 2017

1 reference

1

Laurence Klotz

1 reference

19 August 2017

24 September 2008

1 reference

19 August 2017

World Journal of Urology

1 reference

19 August 2017

26

1 reference

19 August 2017

5

1 reference

19 August 2017

437-442

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-008-0330-8

19 August 2017

0 references

cites work

Prognosis of localised prostatic cancer managed by "watch and wait" policy

1 reference

12 December 2020

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

1 reference

12 December 2020

Quality of life after radical prostatectomy or watchful waiting.

1 reference

12 December 2020

Deferred treatment for prostate cancer

1 reference

12 December 2020

Long-term survival and mortality in prostate cancer treated with noncurative intent

1 reference

12 December 2020

Prostate-specific antigen levels in the United States: implications of various definitions for abnormal

1 reference

12 December 2020

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

12 December 2020

Prostate cancer and the Will Rogers phenomenon.

1 reference

12 December 2020

Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden

1 reference

12 December 2020

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival

1 reference

12 December 2020

Expectant management of localized prostatic cancer

1 reference

12 December 2020

Active surveillance: an individualized approach to early prostate cancer

1 reference

12 December 2020

Carcinoma of the prostate: a 15-year followup

1 reference

12 December 2020

Deferred treatment in clinically localised prostatic carcinoma.

1 reference

12 December 2020

Natural history of localised prostatic cancer managed by conservative therapy alone

1 reference

12 December 2020

Radical prostatectomy versus watchful waiting in early prostate cancer

1 reference

12 December 2020

Long-term survival in a Swedish population-based cohort of men with prostate cancer

1 reference

12 December 2020

Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature

1 reference

12 December 2020

Lead time associated with screening for prostate cancer.

1 reference

12 December 2020

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

1 reference

12 December 2020

PSA doubling time of prostate carcinoma managed with watchful observation alone

1 reference

12 December 2020

Does active surveillance for men with localized prostate cancer carry psychological morbidity?

1 reference

12 December 2020

Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience

1 reference

12 December 2020

20-year outcomes following conservative management of clinically localized prostate cancer

1 reference

12 December 2020

Active surveillance: towards a new paradigm in the management of early prostate cancer

1 reference

12 December 2020

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

1 reference

12 December 2020

The risk of dying of prostate cancer in patients with clinically localized disease

1 reference

12 December 2020

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

12 December 2020

PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section

1 reference

12 December 2020

10.1007/S00345-008-0330-8

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18813934